In federal litigation in Minnesota, Rochester Drug Co-Operative Inc. sued Mylan and other pharmacy benefit managers, alleging a bribery and kickback scheme to favorably place, and increase the price of, the Epi-Pen to the exclusion of other competing epinephrine auto-injector brands, harming RDC by making it pay inflated prices for the Epi-Pen.